SCHEMBL14195909

SCHEMBL14195909

C/C=C/C(=O)c1c(C=O)[nH]c(C(=O)NC(C)(C)C)c1CC

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.44
BRD4 O60885 3/20 0.37
BRPF1 P55201 1/20 0.37
EP300 Q09472 1/20 0.37
CREBBP Q92793 1/20 0.37
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
HTT P42858 1/20 0.30
HDAC3 O15379 1/20 0.30
BRD2 P25440 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7118676 0.69 SMN1; SMN2 (0.57) IGF1RBRD4BRPF1EP300CREBBP
SCHEMBL4494376 0.65 IGF1R (0.79) IGF1RBRD4BRPF1EP300CREBBP
SCHEMBL13919312 0.64 IGF1R (0.48) IGF1RBRD4BRPF1EP300CREBBP
SCHEMBL4498917 0.63 IGF1R (0.54) IGF1RBRD4BRPF1EP300CREBBP
SCHEMBL13919302 0.63 IGF1R (0.76) IGF1RBRD4BRPF1EP300CREBBP
SCHEMBL4208158 0.63 IGF1R (0.76) IGF1RBRD4BRPF1EP300CREBBP
SCHEMBL94996 0.62 IGF1R (1.00) IGF1RALDH1A1POLBKMT2ASMN1; SMN2
SCHEMBL13933186 0.61 IGF1R (0.51) IGF1RALDH1A1POLBKMT2AMAPT
SCHEMBL13933182 0.60 IGF1R (0.50) IGF1RALDH1A1POLBKMT2ASMN1; SMN2
SCHEMBL7122223 0.60 IGF1R (0.71) IGF1RALDH1A1POLBKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076278-A2 METHODS OF CANCER TREATMENT WITH IGF1R INHIBITORS SCHERING CORPORATION (US) 2008-06-26 WO disclosed